A 52-year-old man is evaluated in the hospital for new-onset right flank pain and gross he… — USMLE Step 3

A $52$ -year-old man is evaluated in the hospital for new-onset right flank pain and gross hematuria. He was admitted $6$ days ago for the treatment of a proximal deep vein thrombosis of the left lower extremity. His past medical history is significant for a mechanical aortic valve replacement $5$ years ago, for which he takes warfarin. On admission, his international normalized ratio (INR) was $1.2$ due to several missed doses. He was started on a therapeutic dose of subcutaneous enoxaparin, and his home dose of warfarin was restarted.

Current vital signs are: temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure is $138/86\text{ mm Hg}$ , pulse is $98\text{/min}$ , and respirations are $16\text{/min}$ . Physical examination shows right costovertebral angle tenderness. The left lower extremity edema is unchanged.

Laboratory results today show:
Platelet count: $95,000\text{/mm}^3$ (Admission: $220,000\text{/mm}^3$ )
Creatinine: $1.1\text{ mg/dL}$
INR: $1.8$

A CT venogram of the abdomen and pelvis confirms a right renal vein thrombosis.

Which of the following is the most appropriate next step in pharmacologic management?

Discontinue enoxaparin, discontinue warfarin, administer vitamin K, and initiate intravenous argatrobanAnswer
B
Discontinue enoxaparin, continue warfarin, and initiate intravenous argatroban
C
Discontinue enoxaparin, discontinue warfarin, initiate intravenous argatroban, and administer a platelet transfusion
D
Discontinue warfarin, continue enoxaparin, and add an intravenous unfractionated heparin infusion
E
Discontinue enoxaparin, discontinue warfarin, and hold all anticoagulation until the platelet count exceeds 150,000/mm³

Answer

Discontinue enoxaparin, discontinue warfarin, administer vitamin K, and initiate intravenous argatroban

This patient has developed Heparin-Induced Thrombocytopenia (HIT) complicated by a new thrombosis (renal vein thrombosis). HIT is diagnosed by a

>50\%

drop in platelets (from

220,000\text{/mm}^3

95,000\text{/mm}^3

) typically occurring

5

10

days after heparin exposure. The correct pharmacologic management requires three immediate steps: 1) Discontinuation of all heparin products (enoxaparin). 2) Initiation of a non-heparin anticoagulant, such as a direct thrombin inhibitor (argatroban, bivalirudin) or fondaparinux, to manage the intense hypercoagulable state. 3) Discontinuation and reversal of warfarin with vitamin K. Warfarin rapidly depletes the natural anticoagulant Protein C (which has a short half-life). In a patient with HIT, this creates a severe procoagulant imbalance that commonly leads to venous limb gangrene. Therefore, warfarin must be stopped and reversed until the platelet count recovers to at least

150,000\text{/mm}^3

Step-by-Step Solution

Diagnose Heparin-Induced Thrombocytopenia (HIT).

The patient has a

>50\%

drop in platelets occurring on day

6

of enoxaparin exposure, combined with a new thrombotic event.

Recognizing the 4T score criteria is required before altering the pharmacologic regimen.

Stop all heparin products immediately.

Enoxaparin (low-molecular-weight heparin) must be discontinued.

Continued exposure to heparin fuels the formation of IgG antibodies against platelet factor 4 (PF4)-heparin complexes, worsening thrombosis.

Select an alternative non-heparin anticoagulant.

Intravenous argatroban (a direct thrombin inhibitor) is chosen.

Patients with HIT are in an intensely hypercoagulable state. Stopping heparin is not enough; immediate alternative anticoagulation is required to treat the new renal vein thrombosis.

Address the concurrent warfarin therapy.

Warfarin must be discontinued AND reversed with vitamin K.

Warfarin rapidly depletes Protein C (a natural anticoagulant). In the setting of the massive procoagulant response of HIT, this severe imbalance causes microvascular thrombosis and venous limb gangrene.

Key Concept

Management of Heparin-Induced Thrombocytopenia (HIT) with thrombosis, specifically the requirement to reverse concurrent warfarin therapy to prevent venous limb gangrene.

Estimated Time:2m 0s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic